New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2013
16:33 EDTELN, BIIBElan announces closing of TYSABRI deal with Biogen
Elan (ELN) announced the closing of the TYSABRI collaboration transaction with Biogen Idec (BIIB). The agreement was announced on February 6. Under the terms of the agreement, Elan has received $3.25B in cash and will receive double digit tiered royalty payments, on all indications, for the life of the complete TYSABRI asset. For the first twelve months Elan will receive 12% royalties on in-market sales of TYSABRI, and thereafter, Elan will receive 18% royalties on in-market sales up to $2B and 25% royalties on in-market sales exceeding $2B. In 2012, in-market sales of TYSABRI were $1.6B.
News For ELN;BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
17:07 EDTBIIBBiogen hits fresh lifetime high, levels to watch
Subscribe for More Information
16:13 EDTBIIBBiogen shares jump 5% to $371 after 2015 outlook top estimates
Subscribe for More Information
16:12 EDTBIIBBiogen reports Q4 Tecfidera revenue $916M vs. $397.6M last year
Subscribe for More Information
16:10 EDTBIIBBiogen sees 2015 EPS $16.60-$17.00, consensus $16.37
Subscribe for More Information
16:09 EDTBIIBBiogen reports Q4 EPS $4.09, consensus $3.78
Subscribe for More Information
12:00 EDTBIIBLeerink biotech analysts hold an analyst/industry conference call
Biotech Analyst Schwartz discusses Biogen Idec BIIB037 and whether 2015 will be the year when Amyloid Beta is finally validated as a disease-modifying target in Alzheimer's Disease on an Analyst/Industry conference call to be held on February 3 at 2 pm.
05:30 EDTBIIBBiogen, Fondazione Telethon and Ospedale San Raffaele announce collaboration
Subscribe for More Information
January 27, 2015
15:35 EDTBIIBNotable companies reporting before tomorrow's open
Subscribe for More Information
15:26 EDTBIIBBiogen January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
January 15, 2015
07:29 EDTBIIBOutlook for Biogen trials positive , says RBC Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use